JPMorgan Chase posted strong Q4 results, with EPS up 58% y/y and IB revenues up 46% y/y, beating analyst estimates. Learn ...
The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...
The bank, which owns a minority stake in Viva Wallet, can take over the company in June if its valuation falls before a ...
JPMorgan Chase management disabled comments on an internal webpage where the policy was announced, according to the Wall ...
JPMorgan Chase reported fourth-quarter results Wednesday that came in above analysts' expectations as investment banking fees ...
JPMorgan Chase significantly exceeded fourth-quarter expectations with strong earnings, despite challenges like credit costs ...
Betsy Graseck, an analyst from Morgan Stanley, maintained the Hold rating on JPMorgan Chase & Co. (JPM – Research Report). The associated ...
AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...